Roxithromycin in the therapy of Streptococcus pyogenes throat infections
- 1 January 1987
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 20 (suppl B) , 139-144
- https://doi.org/10.1093/jac/20.suppl_b.139
Abstract
Roxithromycin in two dosage regimens was compared with erythromycin in the therapy of 227 patients with throat infectious due to Streptococcus pyogenes . All three groups had the same clinical efficacy but roxithromycin 300 mg daily was less effective than erythromycin 500 mg qds in eradicating S. pyogenes while there were less antibiotic-related side effects with roxithromycin 150 mg bd than with erythromycin.Keywords
This publication has 0 references indexed in Scilit: